by Roshan Yoganathan | Apr 17, 2014
Recently Revmedx, a pioneer in the biomaterial wound dressing field, made some waves with the commercialization of its product XStatTM . XStatTM received a lot of press because of its FDA approval for use against gunshot wounds and shrapnel-related injuries in the...
by Sasha (Alexandra) Lisovsky | Sep 5, 2013
. I recently spent a week in a rustic New England area hiking, canoeing, tasting local beer, sampling culinary masterpieces and participating in insightful discussions with old and newly acquired friends. It sounds like I had a great vacation; however, I was actually...
by Ubaka Ogbogu | May 2, 2011
A few months ago I wrote about a temporary injunction (ban) issued by United States federal district court judge Royce C. Lamberth on federal funding for research on human embryonic stem cell lines derived from supernumerary IVF embryos. Subsequently, at the request...
by Paul Krzyzanowski | Mar 9, 2011
Patenting report shows disconnect in Canada by Paul Krzyzanowski Got a patentable idea? You might want to move to Switzerland. A recent article in the Globe and Mail compared Canada’s patenting activity to other major countries, and the small European nation...
by Michelle Ly | Feb 22, 2011
As we get further into 2011, embryonic stem (ES) cells continue to be a hot topic. The ability of ES cells to differentiate into virtually any other type of cell makes them a prime avenue for research in biomedical applications. They have also been a source of great...
Comments